highly significantp = 0.001
Notably, plasmablasts from the Advax 10mg group had a highly significant ~5-fold upregulation of AID expression (p = 0.001) when compared to the TIV alone group ( Fig 5A ).
Notably, plasmablasts from the Advax 10mg group had a highly significant ~5-fold upregulation of AID expression (p = 0.001) when compared to the TIV alone group ( Fig 5A ).
Plasmablast generation in the Advax 10mg group (mean area 5.44, SD 3.09) also had a higher point estimate but this did not reach statistical significance when compared to the TIV alone group (p = 0.12).
Given the limited sample size, the confidence intervals in seroprotection and seroconversion rates overlapped between groups in the sub-study, however point estimates showed a clear trend towards higher antibody titer increases in the Advax-adjuvanted groups, with the Advax 10mg dose group achieving the highest point estimates across all three vaccine strains for seroconversion, seroprotection and GMT fold increases across the vaccine strains ( Table 2 ), and it is noted that H1 A/Cal and B/Bris showed more advantage.